Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | +2.26% | +0.74% | +16.74% |
09/05 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
09/05 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.74% | 3.75Cr | |
+39.30% | 72TCr | |
+33.93% | 59TCr | |
-2.83% | 37TCr | |
+20.20% | 33TCr | |
+2.32% | 28TCr | |
+16.83% | 24TCr | |
+9.46% | 21TCr | |
-4.91% | 21TCr | |
+1.22% | 17TCr |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : VYNE Therapeutics Inc. - Special Call